Ashley Turner
Family · Washington, DCNPI 1952876518
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by United Therapeutics Corporation at 26.7% of the total. 2025 is the largest year on record at $1,129, more than ten times the $85 reported in 2021. Among family clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 80 payments — averaging $34.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Therapeutics Corporation$738
- AbbVie$581
- Veloxis Pharmaceuticals, Inc.$309
- Actelion Pharmaceuticals US, Inc.$199
- Takeda Pharmaceuticals U.S.A., Inc.$175
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$124
- plus $642 from 15 others
What the payments were for
- Food & beverage$2,759100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TYVASO$257
- REMODULIN$124
- LIVTENCITY$117
- VRAYLAR$113
- Envarsus$103
How this compares
$2,767 in reported general payments places this provider in the 90th percentile of 392 family providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cinacalcet Hcl | 24 | $16,153 |
| JanuviaSitagliptin Phosphate | 12 | $8,314 |
| JardianceEmpagliflozin | 13 | $6,202 |
| Valganciclovir Hcl | 19 | $2,554 |
| Nifedipine ErNifedipine | 43 | $2,135 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 12 | $1,276 |
| Pantoprazole Sodium | 80 | $875 |
| Labetalol Hcl | 24 | $504 |
| Hydralazine Hcl | 22 | $408 |
| Prednisone | 63 | $382 |
| Tamsulosin Hcl | 54 | $375 |
| Gabapentin | 29 | $348 |
| Carvedilol | 33 | $304 |
| Atorvastatin Calcium | 25 | $185 |
| Amlodipine Besylate | 35 | $181 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $110 | $8,31412 claims |
| Boehringer IngelheimJardiance | $66 | $6,20213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 392 family providers in District of Columbia.
Other family in Washington
- Amy StewartWashington$489K
- Kara CouchWashington$144K
- Laura XandersWashington$109K
- Laura MackeWashington$39K
- Cassandra ThompsonWashington$11K
- Sharmin DiazWashington$9K
- Emily BertrandWashington$8K
- Ana Carrion-GelabertWashington$7K
- Chanda CopelandWashington$7K
- Suad NsouliWashington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.